Stockreport

GH Research Reports Third Quarter 2025 Financial Results and Provides Business Updates

GH Research PLC - Ordinary Shares  (GHRS) 
PDF Engagement with FDA on GH001 IND complete response ongoingFull dataset from the Phase 2b clinical trial of GH001 in TRD reported in July 2025Long-term clinical data on s [Read more]